Temperature Excursion and Suspect Insulin Shipment
A pharmacy in South Portland, Maine, receives a shipment of insulin pens from its primary wholesaler. The shipping container's temperature monitor shows that the product was exposed to 9 degrees Celsius for six hours during transit; the label says storage is 2 to 8 degrees Celsius. When the receiving technician opens the carton, one of the five pen boxes has a lot number that does not match the packing slip, and the carton's tamper-evident seal is wrinkled. The wholesaler's customer service line is closed for the evening. The pharmacy has 12 pens of the same product from an earlier shipment that are properly stored. A patient with type 1 diabetes is waiting for this insulin and says he has only one pen left. The pharmacist must decide what to dispense tonight.
1. How should the pharmacist handle the temperature excursion and the mismatched lot number under DSCSA?
Read the worked answer
Treat the shipment as suspect. The temperature excursion above the labeled storage range is a product-quality issue; the mismatched lot number and wrinkled seal are potential DSCSA illegitimate-product indicators. The pharmacist should quarantine all five boxes, segregate them from dispensable stock, and not dispense any of them. The pharmacist should verify the transaction information and transaction history against the packing slip and the wholesaler's records, contact the wholesaler and manufacturer as soon as possible, and document the temperature data, lot numbers, seal condition, and quarantine location. Under DSCSA, a suspect product must not be distributed; if it is confirmed as illegitimate, the pharmacy must notify FDA and immediate trading partners. The pharmacy should also check whether the excursion product can be returned for credit under the wholesaler's policy.
2. What should the pharmacist tell the patient who needs insulin tonight?
Read the worked answer
Tell the patient that the new shipment is on hold for a quality check and cannot be dispensed tonight. Dispense from the 12 pens that were properly stored, if the prescription and quantity allow, and explain the difference. If 12 pens are not enough to cover his needs until the issue is resolved, contact the prescriber or another pharmacy for an emergency supply; do not substitute the quarantined product. Counsel him on storage and on checking the pen for cloudiness or particles. Document the partial dispense or referral, the patient communication, and the reason the new stock was unavailable.
3. What records and notifications are required if the product is confirmed illegitimate?
Read the worked answer
If the product is confirmed illegitimate, the pharmacy must notify FDA and the immediate trading partners, retain the transaction information and statement, quarantine the product, and follow the recall or return instructions. Do not return it to general stock or destroy it without authorization. Record who was notified, when, and what was found. If any affected product was already dispensed, the pharmacy should identify patients, notify them and their prescribers if the product may be unsafe, and follow the recall communication. The pharmacist-in-charge should review the receiving process to determine why the lot mismatch and seal problem were not caught at check-in.